TY - JOUR
T1 - Effect of a pharmacist intervention on clinically important medication errors after hospital discharge
T2 - A randomized trial
AU - Kripalani, Sunil
AU - Roumie, Christianne L.
AU - Dalal, Anuj K.
AU - Cawthon, Courtney
AU - Businger, Alexandra
AU - Eden, Svetlana K.
AU - Shintani, Ayumi
AU - Sponsler, Kelly Cunningham
AU - Jeff Harris, L.
AU - Theobald, Cecelia
AU - Huang, Robert L.
AU - Scheurer, Danielle
AU - Hunt, Susan
AU - Jacobson, Terry A.
AU - Rask, Kimberly J.
AU - Vaccarino, Viola
AU - Gandhi, Tejal K.
AU - Bates, David W.
AU - Williams, Mark V.
AU - Schnipper, Jeffrey L.
PY - 2012
Y1 - 2012
N2 - Background: Clinically important medication errors are common after hospital discharge. They include preventable or ameliorable adverse drug events (ADEs), as well as medication discrepancies or nonadherence with high potential for future harm (potential ADEs). Objective: To determine the effect of a tailored intervention on the occurrence of clinically important medication errors after hospital discharge. Design: Randomized, controlled trial with concealed allocation and blinded outcome assessors. (ClinicalTrials.gov registration number: NCT00632021) Setting: Two tertiary care academic hospitals. Patients: Adults hospitalized with acute coronary syndromes or acute decompensated heart failure. Intervention: Pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and individualized telephone follow-up after discharge. Measurements: The primary outcome was the number of clinically important medication errors per patient during the first 30 days after hospital discharge. Secondary outcomes included preventable or ameliorable ADEs, as well as potential ADEs. Results: Among 851 participants, 432 (50.8%) had 1 or more clinically important medication errors; 22.9% of such errors were judged to be serious and 1.8% life-threatening. Adverse drug events occurred in 258 patients (30.3%) and potential ADEs in 253 patients (29.7%). The intervention did not significantly alter the per-patient number of clinically important medication errors (unadjusted incidence rate ratio, 0.92 [95% CI, 0.77 to 1.10]) or ADEs (unadjusted incidence rate ratio, 1.09 [CI, 0.86 to 1.39]). Patients in the intervention group tended to have fewer potential ADEs (unadjusted incidence rate ratio, 0.80 [CI, 0.61 to 1.04]). Limitation: The characteristics of the study hospitals and participants may limit generalizability. Conclusion: Clinically important medication errors were present among one half of patients after hospital discharge and were not significantly reduced by a health-literacy-sensitive, pharmacistdelivered intervention. Primary Funding Source: National Heart, Lung, and Blood Institute.
AB - Background: Clinically important medication errors are common after hospital discharge. They include preventable or ameliorable adverse drug events (ADEs), as well as medication discrepancies or nonadherence with high potential for future harm (potential ADEs). Objective: To determine the effect of a tailored intervention on the occurrence of clinically important medication errors after hospital discharge. Design: Randomized, controlled trial with concealed allocation and blinded outcome assessors. (ClinicalTrials.gov registration number: NCT00632021) Setting: Two tertiary care academic hospitals. Patients: Adults hospitalized with acute coronary syndromes or acute decompensated heart failure. Intervention: Pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and individualized telephone follow-up after discharge. Measurements: The primary outcome was the number of clinically important medication errors per patient during the first 30 days after hospital discharge. Secondary outcomes included preventable or ameliorable ADEs, as well as potential ADEs. Results: Among 851 participants, 432 (50.8%) had 1 or more clinically important medication errors; 22.9% of such errors were judged to be serious and 1.8% life-threatening. Adverse drug events occurred in 258 patients (30.3%) and potential ADEs in 253 patients (29.7%). The intervention did not significantly alter the per-patient number of clinically important medication errors (unadjusted incidence rate ratio, 0.92 [95% CI, 0.77 to 1.10]) or ADEs (unadjusted incidence rate ratio, 1.09 [CI, 0.86 to 1.39]). Patients in the intervention group tended to have fewer potential ADEs (unadjusted incidence rate ratio, 0.80 [CI, 0.61 to 1.04]). Limitation: The characteristics of the study hospitals and participants may limit generalizability. Conclusion: Clinically important medication errors were present among one half of patients after hospital discharge and were not significantly reduced by a health-literacy-sensitive, pharmacistdelivered intervention. Primary Funding Source: National Heart, Lung, and Blood Institute.
UR - http://www.scopus.com/inward/record.url?scp=84863644239&partnerID=8YFLogxK
U2 - 10.7326/0003-4819-157-1-201207030-00003
DO - 10.7326/0003-4819-157-1-201207030-00003
M3 - Article
AN - SCOPUS:84863644239
SN - 0003-4819
VL - 157
SP - 1
EP - 10
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 1
ER -